In line with recent KDIGO and Kidney Disease Outcomes Quality Initiative (KDOQI) guidelines, our results support the use of serum albumin as a pragmatic prognostic marker within a broader, multidimensional assessment of nutritional and inflammatory status in ESRD [3,17]. Here, ALB is linked to kidney disorder.